Skip to main content
Caplight Logo









CanSense

CanSense

Private
SwanseaHealthcare & Life Scienceshttps://cansenseltd.com

Last Round

Crowdfunding

Dec 5, 2025

Est. Valuation

$8.32M

Total Funding Raised

$4.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CanSense operates in Healthcare & Life Sciences and is based in Swansea. Its latest recorded funding round was a Crowdfunding round in December 2025.

CanSense is a biotechnology company that develops a non-invasive blood test using AI and laser spectroscopy for the early detection of bowel cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CanSense Comparables

Compare CanSense with similar companies based on industry and business-model similarity.

CanSense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dxcover
86%
Universal Diagnostics
79%
VolitionRx Limited
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CanSense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingDec 5, 2025
GrantApr 28, 2025
GrantJan 28, 2025
GrantNov 11, 2024
GrantNov 23, 2023
Seed
Mar 8, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Adam Bryant

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

CanSense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 110% MoM.

  • Jul 24, 2026

    Monthly visitors grew 273% MoM, reaching 366.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventNov 7, 2026

    CanSense Ltd wins the Innovation, Science and Technology prize at the St David Awards in Wales in 2023 for a test designed to help identify people who may have bowel cancer.

  • receives_awardNov 7, 2026

    In 2023, CanSense Ltd receives the Innovation, Science and Technology prize from the St David Awards in Wales for a test designed to help identify people who may have bowel cancer.

Book a demo to see all news

For institutional investors. Book with your work email.

CanSense Filings

Explore SEC and related filing metadata, where available.

CanSense filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CanSense's valuation, stock price, and market status.

Is CanSense a public or private company?

CanSense is a private company.

What is the current stock price of CanSense?

CanSense is a private company, so its shares have no public market price. Caplight tracks CanSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CanSense worth (valuation)?

CanSense's valuation is estimated at $8.3M based on funding round data.

Can I buy CanSense stock?

CanSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CanSense's last funding round?

CanSense's most recent funding round was Crowdfunding on December 5, 2025.

Who are the main investors in CanSense?

Key investors in CanSense include Innovate UK, Mercia Asset Management, National Institute for Health and Care Research, Development Bank of Wales.

Will CanSense IPO soon?

No public IPO plans have been announced for CanSense.

How can I track CanSense secondary market activity?

Caplight tracks bids, offers, and trades in CanSense's shares on secondary markets.

Firmographic Details

HeadquartersSwansea
Employee Range11
Year Founded2019
Last FundingDec 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?